By Super Admin

Seeking Alpha / - 22 hours ago

Somnigroup to Report Third Quarter 2025 Financial Results

DALLAS, Oct. 15, 2025 /PRNewswire/ -- Somnigroup International, Inc. (NYSE: SGI, "Company" or "Somnigroup") will release its financial results for the third quarter ended September 30, 2025, before the NYSE opening of regular trading on Thursday, November 6, 2025. The Company will hold a...

Seeking Alpha / - 22 hours ago

FRUGA Introduces Passion Fruit: A Healthful, Juicy Twist on Soda

MIAMI, Oct. 15, 2025 /PRNewswire/ -- FRUGA, the soda brand redefining refreshment with real fruit and better-for-you ingredients, is proud to unveil its newest creation: Passion Fruit. After a year and a half perfecting the recipe, FRUGA has crafted a tropical flavor that's as good for...

Seeking Alpha / - 22 hours ago

Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with insulin glargine, meeting the primary endpoint INDIANAPOLIS, Oct. 15, 2025 /PRNewswire/ --...